Literature DB >> 19646750

Laminar-flow immediate-overlay hepatocyte sandwich perfusion system for drug hepatotoxicity testing.

Lei Xia1, Susanne Ng, Rongbin Han, Xiaoye Tuo, Guangfa Xiao, Hwa Liang Leo, Tianming Cheng, Hanry Yu.   

Abstract

Drug hepatotoxicity testing requires in vitro hepatocyte culture to maintain the long-term and stable liver specific functions. We developed a drug testing platform based on laminar-flow immediate-overlay hepatocyte sandwich perfusion culture. The immediate-overlay sandwich (collagen-coated porous polymeric membrane as top overlay) protects the cells and integrity of the top collagen matrix from the impact of flow. A bioreactor was designed that allowed proper control of shear stress and mass transfer. The culture parameters such as the optimal perfusion initiation time and flow rate were systematically and mechanistically determined. The optimized system could re-establish hepatocyte polarity to support biliary excretion and to maintain other liver specific functions, such as the biotransformation enzyme activities, for two weeks that extended the usable in vitro hepatocyte-based drug testing window. When the perfusion cultured hepatocytes from days 7 or 14 were used for drug testing, the APAP-induced hepatotoxicity measurements were more sensitive and consistent over time than the static culture control, enabling further exploitations in large-scale drug testing applications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19646750     DOI: 10.1016/j.biomaterials.2009.07.022

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  15 in total

1.  Bile canaliculi formation by aligning rat primary hepatocytes in a microfluidic device.

Authors:  Yosuke Nakao; Hiroshi Kimura; Yasuyuki Sakai; Teruo Fujii
Journal:  Biomicrofluidics       Date:  2011-06-29       Impact factor: 2.800

2.  Bridging the gap between traditional cell cultures and bioreactors applied in regenerative medicine: practical experiences with the MINUSHEET perfusion culture system.

Authors:  Will W Minuth; Lucia Denk
Journal:  Cytotechnology       Date:  2015-04-17       Impact factor: 2.058

3.  On-chip three-dimensional cell culture in phaseguides improves hepatocyte functions in vitro.

Authors:  Mi Jang; Pavel Neuzil; Thomas Volk; Andreas Manz; Astrid Kleber
Journal:  Biomicrofluidics       Date:  2015-06-23       Impact factor: 2.800

Review 4.  Drug-induced steatohepatitis.

Authors:  Ajit Dash; Robert A Figler; Arun J Sanyal; Brian R Wamhoff
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-10-27       Impact factor: 4.481

5.  On chip two-photon metabolic imaging for drug toxicity testing.

Authors:  Fang Yu; Shuangmu Zhuo; Yinghua Qu; Deepak Choudhury; Zhiping Wang; Ciprian Iliescu; Hanry Yu
Journal:  Biomicrofluidics       Date:  2017-05-11       Impact factor: 2.800

Review 6.  Bioreactor technologies to support liver function in vitro.

Authors:  Mohammad R Ebrahimkhani; Jaclyn A Shepard Neiman; Micha Sam B Raredon; David J Hughes; Linda G Griffith
Journal:  Adv Drug Deliv Rev       Date:  2014-03-05       Impact factor: 15.470

7.  Multi-cellular 3D human primary liver cell culture elevates metabolic activity under fluidic flow.

Authors:  Mandy B Esch; Jean-Matthieu Prot; Ying I Wang; Paula Miller; Jose Ricardo Llamas-Vidales; Brian A Naughton; Dawn R Applegate; Michael L Shuler
Journal:  Lab Chip       Date:  2015-05-21       Impact factor: 6.799

8.  A human liver microphysiology platform for investigating physiology, drug safety, and disease models.

Authors:  Lawrence A Vernetti; Nina Senutovitch; Robert Boltz; Richard DeBiasio; Tong Ying Shun; Albert Gough; D Lansing Taylor
Journal:  Exp Biol Med (Maywood)       Date:  2015-07-22

9.  Dynamic interplay of flow and collagen stabilizes primary hepatocytes culture in a microfluidic platform.

Authors:  Manjunath Hegde; Rohit Jindal; Abhinav Bhushan; Shyam Sundhar Bale; William J McCarty; Inna Golberg; O Berk Usta; Martin L Yarmush
Journal:  Lab Chip       Date:  2014-04-28       Impact factor: 6.799

Review 10.  Experimental models of hepatitis B and C - new insights and progress.

Authors:  Emmanuel Thomas; T Jake Liang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-04-14       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.